ARCUTIS BIOTHERAPEUTIC
10.15
20-九月-24 14:59:59
15 分钟延时
股票
+0.01
+0.10%
今日范围
9.78 - 10.31
ISIN
N/A
来源
NASDAQ
-
Arcutis to Present at Upcoming Investor Conference
11 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2022 Financial Results and Provides Business Update
08 11月 2022 15:02:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter Financial Results
25 10月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
Nationwide Seborrheic Dermatitis Survey Shows Burdensome and Lengthy Path to Diagnosis
21 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 10月 2022 15:00:00 条件 Nasdaq GlobeNewswire
-
26 9月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
20 9月 2022 10:07:40 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Acquisition of Ducentis BioTherapeutics Ltd.
07 9月 2022 16:00:00 条件 Nasdaq GlobeNewswire
-
06 9月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 9月 2022 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Appointment of Neha Krishnamohan to Board of Directors
02 9月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
01 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
23 8月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
22 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
10 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Second Quarter 2022 Financial Results and Provides Business Update
04 8月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
04 8月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 8月 2022 16:55:54 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Announces Pricing of Public Offering of Common Stock
02 8月 2022 20:26:57 条件 Nasdaq GlobeNewswire